This study focused on a dyslipidemia- and glucose metabolic-related FADS1-FADS2 gene cluster, and showed for the first time that FADS gene confers risk to PCOS, independent of dyslipidemia and BMI. The gene discussed is FADS2; the disease is polycystic ovary syndrome.